Categories
Change Password!
Reset Password!
NSAID hypersensitivity significantly reduces quality of life in adults, driven primarily by anxiety around medication safety.
A United States (US)-based study shows that NSAID hypersensitivity substantially impairs quality of life, driven largely by anxiety over medication safety and emergency care exposure.
Nonsteroidal anti-inflammatory drug (NSAID) hypersensitivity reactions are frequently encountered in clinical practice and often trigger medication noncompliance and heightened health-related anxiety. Despite their clinical recognition, the broader psychosocial consequences—particularly their effect on drug-related quality of life (QoL), remain inadequately defined in the US; therefore, investigators undertook a study to determine the impact of NSAID hypersensitivity on QoL among US adults.
Researchers conducted a cross-sectional survey utilizing the validated 15-item Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q) to quantify the burden related to NSAID allergy. Adults with self-reported NSAID hypersensitivity documented were identified via electronic medical records. All eligible individuals were contacted, and completed responses were analyzed to assess QoL impact and associated clinical characteristics. Of 154 adults with documented NSAID allergy, 70 were successfully contacted, and 61 completed the survey.
The cohort was predominantly female (79%), with racial and ethnic distribution reported as 61% White, 38% Black, and 28% Hispanic. A prior NSAID reaction was reported by 87% of participants, most commonly presenting as dyspnea (52%) and rash (33%). The mean DrHy-Q score was 42.87 ± 15.52, indicating a meaningful impairment in drug-related QoL. The most prominent concerns included fear of inadvertent exposure to an allergy-triggering medication during emergency treatment and a strong preference for allergist consultation before NSAID use.
In contrast, day-to-day lifestyle restrictions were described as limited. Comorbid aspirin-exacerbated respiratory disease was present in 34% of respondents, and chronic spontaneous urticaria was reported in 20%, underscoring additional clinical complexity. The study demonstrated that NSAID hypersensitivity imposed a sustained psychosocial burden extending beyond acute reactions, largely fueled by apprehension regarding medication safety in urgent care settings.
Although routine lifestyle disruption was minimal, anxiety surrounding unintended drug exposure significantly influenced patient well-being. The findings emphasized the importance of comprehensive allergy evaluation, structured patient counseling, and consideration of delabeling strategies to diminish unnecessary fear, optimize medication access, and improve overall drug-related QoL.
Journal of Allergy and Clinical Immunology: Global
NSAID drug hypersensitivity in a United States–based population: An assessment of quality of life
Smridhi Mahajan et al.
Comments (0)